Hemophilia B

NICE Rejects CSLā€™s Hemophilia B Gene Therapy

Despite CSL’s hemophilia B gene therapy, NICE is not persuaded

SG Tylor

The UK’s National Institute for Health and Care Excellence (NICE) has expressed hesitation in recommending approval for CSL Behring and ...

FDA Accepts Pfizerā€™s Application for Hemophilia B Gene Therapy Fidanacogene Elaparvovec

FDA Accepts Pfizerā€™s Application for Hemophilia B Gene Therapy Fidanacogene Elaparvovec

SG Tylor

Source – Pfizer On 28 June 2023, Pfizer announced  that the US Food and Drug Administration (FDA) and the European ...